Sarah Alrasheed: New Evidence on Transitioning From Parenteral Prostacyclin to Selexipag
Sarah Alrasheed, Associate Consultant in Pulmonary Medicine at King Faisal Specialist Hospital and Research Center, shared on LinkedIn:
“I am pleased to share that our latest research has been published in Pulmonary Circulation. In this study, we address a critical and sensitive clinical question: the transition from parenteral prostacyclin therapy to Selexipag.
Until now, many of us in clinical practice have had limited evidence to guide whether transitioning to oral prostacyclin pathway therapy is safe and feasible, and most importantly: what the safety implications of this decision are for our patients. Our findings aim to provide practical, real world guidance to support clinicians facing this complex decision.
I hope this work proves valuable for your practice and for the care of patients with pulmonary hypertension.
You can access the article here.”
Article: Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort Study
Authors: Brandon Budhram, Sarah K. Alrasheed, Moaaz Rashad, George Chandy, Anna Dvorkin-Gheva, George A. Fox, Julia Foxall, Andrea Gardner, Doug Helmersen, Naushad Hirani, Kristina Kemp, Mithum Kularatne, David Langleben, Lyda Lesenko, Steeve Provencher, Emma Spence, John R. Swiston, Mitesh Thakrar, Daniel Wadden, Jason Weatherald, Nathan Hambly
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 18, 2026, 18:29Vasee Moorthy: Join WHO Clinical Trial Course Launch at Stand With Science 2026
-
Apr 18, 2026, 18:28Holly O’Byrne: Improving Hemorrhagic Shock Care With a Patient Centered System
-
Apr 18, 2026, 18:26Sthanu Subramanian: CVST as The ‘Great Masquerader’ with Normal Initial CT
-
Apr 18, 2026, 18:25Priyanka Raheja: Sharing the Final Analysis From the Roctavian Phase 1/2 Study
-
Apr 18, 2026, 18:23Jim Hoffman: Reversing Vascular Damage through NETosis Modulation and Efferocytosis Balance
-
Apr 18, 2026, 17:57Abstract Submission Deadline Extended for WSC 2026 – World Stroke Organization
-
Apr 18, 2026, 17:49Leonardo Roever: Progress in Prevention, Treatment, and National Care Strategies for Stroke in China
-
Apr 18, 2026, 17:21Voices of Advocacy in Bleeding Disorders Care – HFA
-
Apr 18, 2026, 16:16Zahra Ghasemi: How a Strategic Plasma Model Transformed Hemophilia Care